Consistent with previous results, under PE treatment, deficiency of GCN5 reduced cardiac hypertrophy marker expression at the mRNA and protein levels (Fig. 4B, Supplementary Fig. 2C). This evidence concerns the gene KAT2B and cardiac hypertrophy.